These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 11161375)

  • 1. Absence of rearrangements in the BRCA2 gene in human cancers.
    Chin SF; Wang Q; Puisieux A; Caldas C
    Br J Cancer; 2001 Jan; 84(2):193-5. PubMed ID: 11161375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Constitutional genomic instability with inversions, duplications, and amplifications in 9p23-24 in BRCA2 mutation carriers.
    Savelyeva L; Claas A; Matzner I; Schlag P; Hofmann W; Scherneck S; Weber B; Schwab M
    Cancer Res; 2001 Jul; 61(13):5179-85. PubMed ID: 11431357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Consistent loss of the wild type allele in breast cancers from a family linked to the BRCA2 gene on chromosome 13q12-13.
    Collins N; McManus R; Wooster R; Mangion J; Seal S; Lakhani SR; Ormiston W; Daly PA; Ford D; Easton DF
    Oncogene; 1995 Apr; 10(8):1673-5. PubMed ID: 7731724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations of the BRCA1 and BRCA2 genes in patients with bilateral breast cancer.
    Steinmann D; Bremer M; Rades D; Skawran B; Siebrands C; Karstens JH; Dörk T
    Br J Cancer; 2001 Sep; 85(6):850-8. PubMed ID: 11556836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allelic imbalance on chromosome 13q: evidence for the involvement of BRCA2 and RB1 in sporadic breast cancer.
    Hamann U; Herbold C; Costa S; Solomayer EF; Kaufmann M; Bastert G; Ulmer HU; Frenzel H; Komitowski D
    Cancer Res; 1996 May; 56(9):1988-90. PubMed ID: 8616837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different tumor types from BRCA2 carriers show wild-type chromosome deletions on 13q12-q13.
    Gudmundsson J; Johannesdottir G; Bergthorsson JT; Arason A; Ingvarsson S; Egilsson V; Barkardottir RB
    Cancer Res; 1995 Nov; 55(21):4830-2. PubMed ID: 7585515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A high occurrence of BRCA1 and BRCA2 mutations among Czech hereditary breast and breast-ovarian cancer families.
    Machácková E; Foretová L; Navrátilová M; Valík D; Claes K; Messiaen L
    Cas Lek Cesk; 2000 Oct; 139(20):635-7. PubMed ID: 11192759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel genomic rearrangements in the BRCA1 gene detected in Greek breast/ovarian cancer patients.
    Armaou S; Konstantopoulou I; Anagnostopoulos T; Razis E; Boukovinas I; Xenidis N; Fountzilas G; Yannoukakos D
    Eur J Cancer; 2007 Jan; 43(2):443-53. PubMed ID: 17174087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA array-based method for detection of large rearrangements in the BRCA1 gene.
    Frolov A; Prowse AH; Vanderveer L; Bove B; Wu H; Godwin AK
    Genes Chromosomes Cancer; 2002 Nov; 35(3):232-41. PubMed ID: 12353265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a novel BRCA1 large genomic rearrangement in a Spanish breast/ovarian cancer family.
    Palanca Suela S; Esteban Cardeñosa E; Barragán González E; Oltra Soler S; de Juan Jiménez I; Chirivella González I; Segura Huerta A; Guillén Ponce C; Martínez de Dueñas E; Bolufer Gilabert P;
    Breast Cancer Res Treat; 2008 Nov; 112(1):63-7. PubMed ID: 18060491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening of male breast cancer and of breast-ovarian cancer families for BRCA2 mutations using large bifluorescent amplicons.
    Pages S; Caux V; Stoppa-Lyonnet D; Tosi M
    Br J Cancer; 2001 Feb; 84(4):482-8. PubMed ID: 11207042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for a BRCA2 rearrangement in high-risk breast/ovarian cancer families: evidence for a founder effect and analysis of the associated phenotypes.
    Machado PM; Brandão RD; Cavaco BM; Eugénio J; Bento S; Nave M; Rodrigues P; Fernandes A; Vaz F
    J Clin Oncol; 2007 May; 25(15):2027-34. PubMed ID: 17513806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Large BRCA1 and BRCA2 genomic rearrangements in Danish high risk breast-ovarian cancer families.
    Hansen Tv; Jønson L; Albrechtsen A; Andersen MK; Ejlertsen B; Nielsen FC
    Breast Cancer Res Treat; 2009 May; 115(2):315-23. PubMed ID: 18546071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low frequency of TSG101/CC2 gene alterations in invasive human breast cancers.
    Wang Q; Driouch K; Courtois S; Champème MH; Bièche I; Treilleux I; Briffod M; Rimokh R; Magaud JP; Curmi P; Lidereau R; Puisieux A
    Oncogene; 1998 Feb; 16(5):677-9. PubMed ID: 9482115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of breast and brain cancer cell growth by BCCIPalpha, an evolutionarily conserved nuclear protein that interacts with BRCA2.
    Liu J; Yuan Y; Huan J; Shen Z
    Oncogene; 2001 Jan; 20(3):336-45. PubMed ID: 11313963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel germline in frame deletion (4128del3) of the BRCA2 gene detected in a breast/ovarian cancer family with fallopian tube and brain tumors identified in the north of France.
    Demange L; Noguchi T; Sauvan R; Moyal-Amsellem N; Birnbaum D; Eisinger F; Sobol H
    Hum Mutat; 2001 Feb; 17(2):155. PubMed ID: 11180606
    [No Abstract]   [Full Text] [Related]  

  • 17. Absence of rearrangements in the tumour susceptibility gene TSG101 in human breast cancer.
    Steiner P; Barnes DM; Harris WH; Weinberg RA
    Nat Genet; 1997 Aug; 16(4):332-3. PubMed ID: 9241265
    [No Abstract]   [Full Text] [Related]  

  • 18. The breast cancer susceptibility gene, BRCA2: at the crossroads between DNA replication and recombination?
    Venkitaraman AR
    Philos Trans R Soc Lond B Biol Sci; 2000 Feb; 355(1394):191-8. PubMed ID: 10724455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MLPA screening in the BRCA1 gene from 1,506 German hereditary breast cancer cases: novel deletions, frequent involvement of exon 17, and occurrence in single early-onset cases.
    Engert S; Wappenschmidt B; Betz B; Kast K; Kutsche M; Hellebrand H; Goecke TO; Kiechle M; Niederacher D; Schmutzler RK; Meindl A
    Hum Mutat; 2008 Jul; 29(7):948-58. PubMed ID: 18431737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TP53 mutations in breast cancer associated with BRCA1 or BRCA2 germ-line mutations: distinctive spectrum and structural distribution.
    Greenblatt MS; Chappuis PO; Bond JP; Hamel N; Foulkes WD
    Cancer Res; 2001 May; 61(10):4092-7. PubMed ID: 11358831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.